Jiangsu Hengrui Medicine Co., Ltd.

This study tested a new injectable drug called HR17031 against a standard insulin (glargine) in Chinese adults whose type 2 diabetes was not well controlled with oral medications. The main goal was to see which treatment was better at lowering long-term blood sugar levels over 26…

This study tested whether combining two different cancer drugs could help control advanced liver cancer in patients whose previous treatment stopped working. The trial involved 190 participants who received both an immunotherapy drug (SHR-1210) and a targeted therapy drug (apatin…

This study tested whether HR19042 capsules could help people with IgA nephropathy, a kidney disease where protein leaks into urine. Researchers compared the capsules against placebo pills in 316 adults with confirmed kidney damage. The main goal was to see if the treatment could …

This study tested whether combining an immunotherapy drug (SHR-1210) with either a targeted therapy (apatinib) or standard chemotherapy could help people with advanced liver or bile duct cancer. It involved 157 participants whose cancer had spread and was not suitable for surgery…

This study tested whether a new oral drug called pyrotinib works better than standard chemotherapy (docetaxel) for people with advanced non-squamous lung cancer that has a specific HER2 gene mutation and has worsened after initial platinum-based chemotherapy. About 150 participan…

This study tested whether adding a second drug (rivoceranib) to a standard immunotherapy (camrelizumab) is better at preventing liver cancer from returning after initial surgery or ablation. It involved 251 patients who were at high risk of their cancer coming back. The goal was …

This study tested whether a new injectable medication called HR17031 works better and is safer than a standard long-acting insulin (glargine) for adults with type 2 diabetes. It involved 393 people whose blood sugar was not well controlled on their current insulin and pill regime…

This study tested a new muscle relaxant drug called HRS-9190 for use during surgery. It was compared to the standard drug rocuronium in 70 adults having elective surgery. Researchers measured how well it worked for placing breathing tubes and how quickly patients recovered muscle…

This study tested the safety and early effectiveness of an experimental drug called SHR-A1811 in people with advanced solid tumors that have a specific marker called HER2. The trial involved 396 participants whose cancer had progressed despite standard treatments. Researchers mon…

This was the first study in people to test a new oral drug called HRS7415 for advanced cancers. It involved 38 patients and aimed to find a safe dose and understand how the body processes the drug. The main goals were to check for side effects and see if the drug showed any early…

This study tested if a new oral tablet (SHR7280) works as well as a standard injection (ganirelix) for women undergoing IVF. The goal was to prevent early ovulation during the egg-stimulation phase of treatment. About 317 married women with infertility participated to see if the …

This study tested a combination of two drugs, SHR-1210 and apatinib, for people with advanced non-small cell lung cancer whose cancer had grown after standard chemotherapy. The main goals were to see how safe the combination was and how well it worked to shrink tumors. It involve…

This large study tested whether adding two newer drugs (camrelizumab and apatinib) to standard chemotherapy works better than chemotherapy alone for advanced stomach cancer. The trial involved 885 patients who hadn't received previous treatment for their advanced cancer. Research…

This study tested whether a new medication called HR091506 works as well as an existing drug (febuxostat) to lower uric acid and control gout in adults. It involved 765 people with gout and high uric acid levels over 28 weeks. The main goal was to see if the new pill could safely…

This early-stage study tested a new drug called SHR-A1811 in 101 patients with advanced stomach or colorectal cancer that had stopped responding to standard treatments. The main goals were to find a safe dose and check for early signs that the drug might help control these cancer…

This study tested a drug called remimazolam to see if it could safely keep adult ICU patients comfortably sedated while they were on a breathing machine for at least three days. The main goal was to see how well the drug maintained the right level of sleep without needing extra r…

This study tested whether a medication called remimazolam could safely and effectively keep ICU patients sedated at the right level while they were on breathing machines. Researchers compared it to another active sedative in 214 adult ICU patients who needed at least 6 hours of s…

This was an early safety study of a new drug called HRS-9190, designed to relax muscles during surgery. It tested the drug in 49 healthy adults to see if it was safe, how the body handled it, and how well it worked. The study also looked at how another drug could reverse its effe…

This study tested how an antibiotic called rifampicin affects the way the body processes an experimental prostate cancer drug called HRS-5041. Researchers gave both drugs to 16 healthy male volunteers to measure drug levels in their blood. The goal was to understand potential dru…

This study looked at how a new injection for severe pain after surgery, called SHR8554, moves through and leaves the bodies of people with reduced kidney function. It compared 20 participants, some with kidney problems and some healthy, to see if the drug behaves differently. The…

This study aimed to observe the safety of the sedative drug remazolam in real-world medical practice. It followed 2000 patients in China who received the drug for sedation during painless stomach and colon examinations. The main goal was to collect information on any side effects…

This early-stage study aimed to understand how a new drug called SHR7280 might interact with five other common medications. It involved 20 healthy male volunteers to see if taking SHR7280 changes how the body processes these other drugs. The main goal was to gather safety data, n…

This study observed over 1,200 patients in China who received the sedative drug remimazolam during surgery or a lung exam called a bronchoscopy. The goal was to collect real-world information on the drug's safety and any side effects. It was an observational study, meaning patien…

This early-stage study tested a new muscle relaxant called HRS-9190 in healthy adults to see if it's safe and how the body processes it. Researchers gave increasing doses to 53 healthy volunteers aged 18-45 and monitored for side effects. The main goal was to understand how much …

This study aimed to see if a new, experimental long-acting pain injection works the same way in the body as an already approved version. It involved 36 healthy volunteers who received both injections. Researchers measured drug levels in the blood to compare them and checked for s…